MedPath

Home Care Management of Pediatric Pain

Phase 4
Completed
Conditions
Tonsillectomy
Interventions
Other: Standard Care
Other: As needed dosing
Other: ATC Dosing
Other: Structured Pain Management Program
Registration Number
NCT00251628
Lead Sponsor
University of California, San Francisco
Brief Summary

The purpose of this study is to determine whether around-the-clock dosing of pain medication, with or without nurse coaching, increases the effectiveness of pain management (i.e., decreased pain intensity scores with and without swallowing, increased use of pain medication, improved sleep, increased oral intake of fluids, decreased negative behaviors, and the same degree of side effects), over time, compared to standard care with "as needed" dosing.

Detailed Description

The undertreatment of postoperative pain in children remains a critical problem. Only recently have clinical trials begun to evaluate the efficacy of pharmacologic interventions in the management of postoperative pain beyond the immediate postoperative recovery period and after discharge home following tonsillectomy. Given the fact that approximately 50% of pediatric surgeries are done on an outpatient basis, this study has the potential to improve the home pain management of thousands of children. This study is one of the first to evaluate in a systematic fashion the use of an around-the-clock dosing of a weight appropriate dose of a nonopioid/opioid combination analgesic compared to as needed dosing. Because the study will evaluate the effectiveness of both a behavioral intervention and two different pharmacologic interventions, it will provide important information that should have a direct clinical application in the management of children's pain.

The consent form is written according to the standards outlined by the Committee on Human Research, including: 1) an explanation of the purposes of the research and the expected duration of the subject's participation; 2) a description of the procedures to be followed; 3) a description of any foreseeable risks or benefits to the subject, and any alternative courses of treatment; 4) a statement describing the extent to which confidentiality of records will be maintained; 5) a statement whether compensation will be provided and medical treatment made available if injury occurs; 6) the name and number of the Chair of the Committee on Human Research; 7) a statement that participation is voluntary, and that the subject may discontinue participation at any time; and 8) a statement indicating that the subject has received a copy of the consent document and related materials. A separate form is signed to authorize access to their health care information.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
211
Inclusion Criteria
  • Outpatient tonsillectomy, with or without other minor procedures (e.g., ear tube placement); parental consent; child assent (age-appropriate); ability of the child to speak English; ability of the parents to read, write, and speak English; and, access to a telephone.
Exclusion Criteria
  • History of severe obstructive sleep apnea (causing the child to stop breathing repeatedly during sleep); known problems with vision, hearing, control and coordination of movement, or thinking ability.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Group AAs needed dosing-
Group AStandard Care-
Group BStandard Care-
Group BATC Dosing-
Group CATC Dosing-
Group CStructured Pain Management Program-
Primary Outcome Measures
NameTimeMethod
Determine the effectiveness of pain management "over time", compared to standard care with "as needed" dosing.Morning and evening for 3 days following surgery
Secondary Outcome Measures
NameTimeMethod
Pain intensityMorning and evening for 3 days following surgery
Severity of opioid-related adverse effects (i.e., nausea, vomiting, constipation, daytime sedation, lightheadedness or feeling dizzy, and nightmares)Every evening for 3 days following surgery
Volume and number of times pain medication administeredwith each dose for 3 days following surgery

Trial Locations

Locations (1)

Children's Hospital Central California

🇺🇸

Madera, California, United States

© Copyright 2025. All Rights Reserved by MedPath